clinical trial · NCT07456059
A Study to Evaluate EDG-7500 in Caucasian and Japanese Adults
Healthy Adult ParticipantsEDG-7500
brief summary
The purpose of this Phase 1 study is to understand and compare the amount of EDG-7500 in the blood after single and multiple doses in Japanese and Caucasian adults. The safety of EDG-7500 in these adult participants will also be evaluated in this study.
started
Mar 1, 2026
primary completion
Jun 1, 2026
completion
Jun 1, 2026
last updated
Mar 6, 2026
official title
A Phase 1, Single-center, Open-label, Study to Investigate the Safety, Tolerability, and Pharmacokinetics of a Single Dose and Multiple Doses of EDG-7500 in Healthy Adult Caucasian and Japanese Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol